Insider Trading Activity Corcept Therapeutics Incorporated (NASDAQ:CORT) – Director Sold 23,006 shares of Stock

ME Staff
-
0

Insider Trading Activity For Corcept Therapeutics Incorporated (NASDAQ:CORT)

David L Mahoney , Director of Corcept Therapeutics Incorporated (NASDAQ:CORT) reportedly Sold 23,006 shares of the company’s stock at an average price of 12.5 for a total transaction amount of $287,575.00 SEC Form

Insider Trading History For Corcept Therapeutics Incorporated (NASDAQ:CORT)

  • On 11/7/2012 G Leonard Baker Jr, Director, bought 300,000 with an average share price of $1.83 per share and the total transaction amounting to $549,000.00.View SEC Filing
  • On 11/23/2012 Daniel Bradbury, Director, bought 179,000 with an average share price of $1.39 per share and the total transaction amounting to $248,810.00.View SEC Filing
  • On 12/5/2012 G Leonard Baker Jr, Director, bought 87,131 with an average share price of $1.46 per share and the total transaction amounting to $127,211.26.View SEC Filing
  • On 3/14/2013 Joseph L Turner, Director, bought 10,000 with an average share price of $2.01 per share and the total transaction amounting to $20,100.00.View SEC Filing
  • On 3/7/2014 Longitude Venture Partners L.P, Director, sold 250,000 with an average share price of $4.00 per share and the total transaction amounting to $1,000,000.00.View SEC Filing
  • On 4/1/2014 Patrick Enright, Director, sold 250,000 with an average share price of $4.28 per share and the total transaction amounting to $1,070,000.00.View SEC Filing
  • On 5/2/2014 Longitude Venture Partners L.P, Director, sold 250,000 with an average share price of $4.11 per share and the total transaction amounting to $1,027,500.00.View SEC Filing

    • Analyst Ratings For Corcept Therapeutics Incorporated (NASDAQ:CORT)
    These are 1 Sell Rating, 3 Buy Ratings .
    The current consensus rating for Corcept Therapeutics Incorporated (NASDAQ:CORT) is Buy (Score: 2.50) with a consensus target price of $14.25 , a potential (10.04% upside)

    Analyst Ratings History For Corcept Therapeutics Incorporated (NASDAQ:CORT)

    • On 11/2/2016 FBR & Co Set Price Target of rating Buy with a price target of $12.00
    • On 12/20/2016 Janney Montgomery Scott Initiated Coverage of rating Sell with a price target of $7.00
    • On 5/15/2017 Piper Jaffray Companies Set Price Target of rating Buy with a price target of $18.00
    • On 7/18/2017 Ladenburg Thalmann Financial Services Set Price Target of rating Buy with a price target of $15.00 to $20.00

    Recent Trading Activity for Corcept Therapeutics Incorporated (NASDAQ:CORT)
    Shares of Corcept Therapeutics Incorporated closed the previous trading session at 12.95 up +0.07 0.54% with 953,569 shares trading hands.